Key Events This Week
7 Sep: Stock surges 10.41% to ₹133.15 on technical upgrade announcement
8 Sep: Technical momentum confirmed with bullish indicators and stable price
9 Sep: Price holds steady at ₹132.25 amid declining market sentiment
10 Sep: Minor dip to ₹132.00 as volume tapers
11 Sep: Week closes at ₹127.95, down 3.07% on final session
7 September: Sharp Rally on Technical Upgrade
Themis Medicare Ltd opened the week with a remarkable 10.41% gain, closing at ₹133.15 on 7 Sep 2026. This surge coincided with MarketsMOJO’s upgrade of the stock’s rating from 'Strong Sell' to 'Sell', driven by improved technical indicators despite weak fundamentals. The stock reached an intraday high of ₹141.05, reflecting strong buying interest. This performance starkly contrasted with the Sensex, which declined 0.46% to 36,218.97, underscoring Themis Medicare’s relative strength amid broader market weakness.
8 September: Technical Momentum Consolidates
On 8 Sep, the stock price marginally retreated by 0.68% to ₹132.25, maintaining most of the previous day’s gains. The technical momentum remained bullish, supported by weekly MACD and Bollinger Bands expansions. The Relative Strength Index (RSI) stayed neutral, indicating room for further upside without overbought conditions. The Sensex continued its downward trend, falling 0.21% to 36,144.32, further highlighting Themis Medicare’s outperformance.
This week's revealed pick, a Large Cap from Public Banks with TARGET PRICE, is already showing movement! Get the complete analysis before it's too late.
- - Target price included
- - Early movement detected
- - Complete analysis ready
9 September: Price Stabilises Amid Market Weakness
The stock price remained unchanged at ₹132.25 on 9 Sep, despite the Sensex dropping 0.62% to 35,921.77. This stability amid a declining market reflects investor confidence in the stock’s technical outlook. However, volume declined sharply to 14,285 shares, and On-Balance Volume (OBV) showed no clear trend, suggesting cautious participation. The Know Sure Thing (KST) indicator presented mixed signals, mildly bearish weekly but mildly bullish monthly, indicating some short-term uncertainty.
10 September: Minor Decline with Reduced Volume
On 10 Sep, Themis Medicare edged down 0.19% to ₹132.00 on low volume of 9,848 shares. The stock remained above key moving averages, maintaining its bullish technical stance. The Sensex was nearly flat, down 0.03% at 35,912.77. The muted price action and volume suggest a consolidation phase following the earlier rally, with investors awaiting further confirmation of trend sustainability.
Why settle for Themis Medicare Ltd? SwitchER evaluates this micro-cap against peers, other sectors, and market caps to find you superior investment opportunities!
- - Comprehensive evaluation done
- - Superior opportunities identified
- - Smart switching enabled
11 September: Week Ends with a Pullback
The stock closed the week at ₹127.95, down 3.07% on the day, on volume of 12,775 shares. This decline followed four sessions of relative strength and may reflect profit-taking or caution ahead of further fundamental developments. The Sensex also declined 0.39% to 35,773.24, marking a weak finish to the week. Despite the pullback, Themis Medicare outperformed the benchmark by a wide margin over the full week, gaining 6.09% versus the Sensex’s 1.68% loss.
Weekly Price Performance: Themis Medicare vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-09-07 | ₹133.15 | +10.41% | 36,218.97 | -0.46% |
| 2026-09-08 | ₹132.25 | -0.68% | 36,144.32 | -0.21% |
| 2026-09-09 | ₹132.25 | 0.00% | 35,921.77 | -0.62% |
| 2026-09-10 | ₹132.00 | -0.19% | 35,912.77 | -0.03% |
| 2026-09-11 | ₹127.95 | -3.07% | 35,773.24 | -0.39% |
Key Takeaways
Technical Momentum Drives Gains: Themis Medicare’s 6.09% weekly gain was primarily fuelled by a significant technical upgrade from MarketsMOJO, shifting the rating from 'Strong Sell' to 'Sell' based on bullish MACD, Bollinger Bands, and moving averages. This technical shift triggered strong buying interest, especially on 7 Sep.
Outperformance Amid Market Weakness: The stock consistently outperformed the Sensex throughout the week, which declined 1.68%. This relative strength highlights the stock’s appeal to traders focusing on technical signals rather than fundamentals.
Fundamental Challenges Persist: Despite the technical improvements, Themis Medicare continues to face weak financials, including significant operating losses and high promoter share pledging. These factors maintain a cautious overall outlook.
Volume and Confirmation Signals Mixed: The lack of clear volume confirmation via OBV and mixed KST readings suggest that while momentum is positive, broader market participation remains tentative, warranting close monitoring.
Short-Term Consolidation Evident: The minor price declines and volume tapering towards week-end indicate a consolidation phase, possibly reflecting profit-taking or uncertainty ahead of further fundamental updates.
Conclusion
Themis Medicare Ltd’s week was characterised by a strong technical-driven rally that lifted the stock 6.09%, significantly outperforming the Sensex’s 1.68% decline. The MarketsMOJO upgrade to a 'Sell' rating on 7 Sep, reflecting improved technical indicators, was the key catalyst behind the initial surge and sustained momentum. However, the company’s weak fundamentals and high promoter share pledging continue to pose risks, tempering enthusiasm for a sustained recovery.
Investors should weigh the positive technical signals against the underlying financial challenges and monitor volume trends and technical indicators closely for confirmation of a durable uptrend. The stock’s micro-cap status adds volatility, making cautious observation essential in the near term.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
